ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Nephrology

Top Nephrology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIO ALMEIDA SUAREZ MD

Nephrology

25,167

$1.47M

888
816 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 29%

$58
Average prescription price

Avg: $112

SHRIRAM MARATHE MD

Nephrology

21,075

$1.31M

895
445 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $112

CARMEN ORTIZ BUTCHER MD

Nephrology

20,031

$4.97M

609
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 29%

$248
Average prescription price

Avg: $112

GUSTAVO SERRANO MD

Nephrology

18,872

$1.26M

629
420 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $112

STEVEN ZEIG MD

Nephrology

16,348

$781K

713
616 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $112

MIGUEL PORTOCARRERO MD

Nephrology

15,130

$638K

974
698 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 29%

$42
Average prescription price

Avg: $112

GIL CU MD

Nephrology

13,516

$1M

691
525 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$74
Average prescription price

Avg: $112

MICHAEL ACHINGER MD

Nephrology

11,067

$622K

820
721 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $112

THOMAS CURRY M.D.

Nephrology

9,482

$497K

300
260 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $112

FRANCISCO PONS MD

Nephrology

8,758

$814K

697
616 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 29%

$93
Average prescription price

Avg: $112

ERNESTO PINZON MD

Nephrology

8,696

$794K

524
433 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 29%

$91
Average prescription price

Avg: $112

MARK STAMPFL MD

Nephrology

8,419

$553K

669
559 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $112

CHRISTOPHER MAI M.D.

Nephrology

8,327

$739K

557
486 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 29%

$89
Average prescription price

Avg: $112

STEVEN ACHINGER MD

Nephrology

7,536

$470K

531
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $112

WAYNE RODRIGUEZ MD

Nephrology

6,990

$423K

419
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $112

RAMIRO MARRERO MD

Nephrology

6,956

$256K

182
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 29%

$37
Average prescription price

Avg: $112

PETER GILBERT MD

Nephrology

6,864

$426K

347
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $112

WARREN KUPIN MD

Nephrology

6,696

$1.24M

285
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 29%

$185
Average prescription price

Avg: $112

ALAN SALLMAN M.D.

Nephrology

6,617

$616K

352
255 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 29%

$93
Average prescription price

Avg: $112

JORGE LARRANAGA MD

Nephrology

6,392

$852K

590
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 29%

$133
Average prescription price

Avg: $112

JORGE BARRERO M.D.

Nephrology

6,376

$1.03M

396
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 29%

$161
Average prescription price

Avg: $112

CLYDE PENCE MD

Nephrology

6,372

$707K

382
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 29%

$111
Average prescription price

Avg: $112

JORGE DIEGO MD

Nephrology

6,293

$1.56M

372
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 29%

$247
Average prescription price

Avg: $112

VINOD PATEL M.D.

Nephrology

6,251

$928K

347
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 29%

$149
Average prescription price

Avg: $112

JOSEPH WARREN M.D.

Nephrology

5,991

$679K

369
201 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 29%

$113
Average prescription price

Avg: $112

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank